VSM MedTech Ltd. (VSM.TO) Buy, Sell or Hold

VSM MedTech Ltd. (VSM.TO)

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

0.00

-0.00 (0.00%)

0 watching

BUY

Has a pretty high valuation right now, but has potential to grow into it. Demand for their product has great upside. Probable takeover down the road.

TOP PICK

A highly speculative stock. Has tripled in price. Just sold their seventh machine.

BUY

Has just hit an all-time high. This price represents an excellent buying opportunity. Expect them to sell 12 or13 of their systems this year at $2 million each.

STRONG BUY

Reimbursements for the tests have doubled in the US.To be a takeover down the road.Looks very attractive.Should have explosive growth ahead of it.

PAST TOP PICK

(Was the top pick on May 20/03.Up 256%.)Still likes.Sold half of their shares.Could drop to five dollars but will still keep.

BUY

Looks like a very strong situation.Getting some favorable announcements.A very competent company.

BUY

One of the best stories he's heard in a long time.Has done exceptionally well.Selling their product globally.Margins are over 50%.A buy and hold stock.

WEAK BUY

Well ranked in their Quant database model. The question is, can they deliver the earnings growth that is forcast. Their procedure has been approval for coverage ny insurance. Expensive.

BUY

A great company. Has a little concern on the dramatic price rise. Great growth prospects as there is growing customer demand.

TOP PICK

Has 85% market share of meg(?) machines. Will probably earn 6/7% per share this year.

TOP PICK

Improving operationally. Sales are increasing by 100% from last year. Profitable.

DON'T BUY

Well run. Expect they may be currently trying to raise money.

TOP PICK

New TSX listing. Good sales. Good contracts.

Showing 46 to 58 of 58 entries

Most Recent Experts

Joe Terranova

Virtus Investment Partners

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Gordon Reid

GoodReid Investment Counsel

Jim Cramer - Mad Money

CNBC

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Summer Sale

VSM MedTech Ltd. (VSM.TO)